MedPath

To see the effect of Shatpushpa taila Nasya and Shatpushpa Taila Matrabasti with Tilamooladi churan in the management of Pushpaghni wsr to Polycystic Ovarian Syndrome

Phase 2
Not yet recruiting
Conditions
Polycystic ovarian syndrome,
Registration Number
CTRI/2020/08/027436
Lead Sponsor
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Brief Summary

A randomised controlled trial in which 15 Patients will receive Shatpushpa taila Nasya with tilamooladi churna and 15 Patients will receive Shatpushpa taila Matrabasti along with Tilamooladi Churna suffering form Polycystic Ovarian Syndrome

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

Fullfill at least 2 of the following:- 1.Oligomenorrhea and/or anovulation 2.Hyperandonism (Clinical and/or bio-chemical) 3.PCOS-Diagnosed by Trans Vaginal Sonography (TVS In married)and USG Abdomen in unmarried.

Exclusion Criteria
  • •Any other cause of oligomenorrhea and anovulation excluding PCOD.
  • •Any organic lesion like adrenal or ovarian.
  • •Congenital anomalies and any other pelvic pathology.
  • •Patients having STDs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in signs and symptoms of patients2 months
Oligomenorrhea,Hypomenorrhea, Dysmenorrhoea,Menorrhagia2 months
Secondary Outcome Measures
NameTimeMethod
Efficacy of the medicine onObesity,Acne, Hirsutism

Trial Locations

Locations (1)

University College of Ayurveda

🇮🇳

Jodhpur, RAJASTHAN, India

University College of Ayurveda
🇮🇳Jodhpur, RAJASTHAN, India
Dr Rashmi Sharma
Principal investigator
9166607559
vd_rashmi11@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.